Skip to main content
60°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ocugen Inc
(NQ:
OCGN
)
1.300
+0.070 (+5.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocugen Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
32
33
Next >
Ocugen CSO to Participate in 4th Annual Dry AMD Therapeutic Development Summit
November 07, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen to Host Conference Call on Thursday, November 9 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2023 Financial Results
November 02, 2023
From
Ocugen
Via
GlobeNewswire
Why Is Archer Aviation (ACHR) Stock Moving Today?
October 10, 2023
Archer Aviation stock is on a wild ride Tuesday morning after a short report targeting one of its rivals sent ACHR shares down this morning.
Via
InvestorPlace
A Preview Of Ocugen's Earnings
August 21, 2023
Via
Benzinga
Can Pat Toomey Save Ocugen (OCGN) Stock?
June 05, 2023
Shares of OCGN stock received a boost this morning following the addition of some high-profile names to Ocugen's advisory board.
Via
InvestorPlace
Why Is Ocugen (OCGN) Stock Up 5% Today?
October 10, 2023
Ocugen stock is rising higher on Tuesday thanks to OCGN investors celebrating news of a new clinical trial for its Covid-19 vaccine.
Via
InvestorPlace
Exposures
COVID-19
Ocugen Mucosal Vaccine Candidate OCU500 Selected by NIH/NIAID Project NextGen for Inclusion in Clinical Trials
October 10, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen to Present at the 2023 Cell & Gene Meeting on the Mesa
October 04, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen CSO to Participate in 4th Annual Gene Therapy for Ophthalmic Disorders Conference
September 29, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines Conference
September 27, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen, Inc. Announces Connie Collingsworth Joins Business Advisory Board
September 21, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen to Participate in Panel at Cantor Fitzgerald Global Healthcare Conference 2023
September 20, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen Announces Positive Clinical Study Update from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA)
September 13, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen to Host Virtual Investor & Analyst Event on September 13, 2023
September 12, 2023
Company to share updated results from ongoing Phase 1/2 trial of OCU400 for the treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis
From
Ocugen
Via
GlobeNewswire
Ocugen (OCGN) Q2 2023 Earnings Call Transcript
August 22, 2023
OCGN earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Ocugen Provides Business Update with Second Quarter 2023 Financial Results
August 21, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen to Host Conference Call on Tuesday, August 22 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2023 Financial Results
August 18, 2023
From
Ocugen
Via
GlobeNewswire
3 Millionaire-Maker Growth Stocks to Buy Before the Window
July 25, 2023
Although millionaire-maker stocks to buy present wildly outrageous risks, the intrepid may find opportunity in these ideas.
Via
InvestorPlace
7 Biotech Stocks to Sell in July
July 13, 2023
Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July.
Via
InvestorPlace
7 Doomed Growth Stocks Destined for Disaster
July 12, 2023
Investing in growth stocks can be very expensive. Save yourself some time and money by avoiding these doomed growth stocks to sell.
Via
InvestorPlace
Ocugen CEO & CSO to Present at 41st Annual AAPI Convention and Scientific Assembly
June 30, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
June 20, 2023
The Dow Jones closed lower by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested...
Via
Benzinga
Ocugen, Inc. Announces Adjournment of Annual Meeting of Shareholders
June 09, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen, Inc. Announces Business Advisory Board
June 05, 2023
From
Ocugen
Via
GlobeNewswire
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?
May 25, 2023
These companies haven't given up on the coronavirus vaccine market.
Via
The Motley Fool
5 Investors Betting Big on Ocugen (OCGN) Stock Right Now
May 24, 2023
Ocugen has been falling after announcing a new share offering. But that's not the only reason hedge funds are moving away from OCGN stock.
Via
InvestorPlace
Crude Oil Rises 2%; Kohl's Reports Surprise Q1 Profit
May 24, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 250 points on Wednesday. The Dow traded down 0.73% to 32,813.21 while the NASDAQ fell 0.77% to 12,463.32. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 24, 2023
Via
Benzinga
Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 24, 2023
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares jumped 209.1% to $0.5622 after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods.
Via
Benzinga
Nasdaq Down 1%; US Crude Oil Inventories Decline Last Week
May 24, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Wednesday. The Dow traded down 0.72% to 32,816.38 while the NASDAQ fell 1.12% to 12,419.97. The...
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.